ARA-290 16 MG

ARA-290 is a synthetic peptide derivative structurally related to the erythropoietin (EPO) helix-B surface peptide. It has been developed as a stabilized analog for research purposes and is primarily studied in laboratory settings for its potential effects on tissue protection, inflammation modulation, and peptide pharmacology. Preclinical studies have investigated ARA-290 in relation to experimental models of neuropathy, ischemia, and inflammatory injury.

Research involving ARA-290 commonly explores:

• Its role in activating the innate repair receptor (IRR) to promote anti-inflammatory and tissue-protective signaling in cellular and animal models.
• Possible contributions to neuroprotection and attenuation of neuropathic pain in models of small fiber neuropathy and chronic nerve injury.
• Experimental reduction of tissue damage and fibrosis following ischemic or inflammatory insults in controlled studies.
• Its activity in studies of wound healing, autoimmune disease, and recovery from injury, where the short EPO-mimetic sequence and receptor selectivity are topics of interest.
ARA-290 is provided as a lyophilized powder for laboratory research use only (RUO). It is not intended for diagnostic, therapeutic, or clinical applications and must not be used in humans or animals.

Product details:

• Synonyms: Cibinetide, EPO-mimetic peptide, Helix B surface peptide (HBSP)
• Purity: ≥98%
• CAS Number: 75539-63-0
• Molecular Formula: C64H111N21O17
• Molecular Weight: Approximately 1454.69 Da
• Appearance: White to off-white lyophilized powder

This product is intended exclusively for scientific research and laboratory investigation in compliance with applicable regulatory guidelines.